Tara E. Seery, MD

Dr. Lee is board certified in transplant hepatology and gastroenterology at Hoag Digestive Institute. He practices in Newport Beach and Irvine with a focus on patient care in the diagnosis and treatment of complex liver diseases. His clinical interests include liver cancer, autoimmune liver diseases and alloimmune complications after liver transplantation. In addition to evidence-based medicine, Dr. Lee believes in understanding the stories of each patient and providing individualized care, valuing each patient as distinct rather than generalized by one’s condition. Dr. Lee earned his medical degree from Rush Medical College at Rush University Medical Center in Chicago, Ill. and completed his residency in internal medicine and fellowship in gastroenterology at the University of Southern California/LAC+USC in Los Angeles. While there, he was awarded Intern of the Year and the USC Choi Family Excellence in Patient-Centered Care Award as a fellow. He then went on to complete his fellowship in transplant hepatology at Icahn School of Medicine at Mount Sinai in New York. His undergraduate degrees include a Bachelor of Science in both biology and chemistry from University of California, Irvine. Dr. Lee is a member of professional organizations including the American Association for the Study of Liver Diseases and American Society of Transplantation, allowing him to contribute to the medical community as a member and peer reviewer. Additionally, he has participated in several educational presentations on topics such as immunosuppression after liver transplantation, acute liver failure, liver disease and hepatitis. He is well-published in numerous medical journals, research abstracts and book chapters. He served as Clinical Assistant Professor of Medicine for the Department of Gastroenterology and Hepatology at Loma Linda University prior to his arrival at Hoag.

Gary A. Ulaner, M.D., Ph.D., F.A.C.N.M., joins Hoag Family Cancer Institute as the Director of Molecular Imaging and Therapy.Dr. Ulaner was previously with Memorial Sloan Kettering Cancer Center, where he served as the PET/CT expert on the Breast Cancer Disease Management Team. Dual board-certified in radiology and nuclear medicine, Dr. Ulaner is a nationally recognized expert in the use of targeted imaging to help direct focused cancer therapies. He leads several National Institutes of Health (NIH) clinical trials in molecular imaging and therapeutics, including two active NIH R01 grants, and has received more than $8 million in extramural funding.Dr. Ulaner has received multiple honors throughout his career. He was elected Fellow of the American College of Nuclear Medicine, received an award for breast cancer research from the Susan Komen Foundation, and was the first Hal O'Brien Rising Star from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), among other accolades.Dr. Ulaner has authored or co-authored more than 110 peer-reviewed manuscripts and has given more than 110 clinical presentations, both nationwide and internationally, in addition to writing the textbook Fundamentals of Oncologic PET/CT, published in both English and Spanish. He is also on the editorial boards of several leading clinical journals including: Radiology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, and Clinical Nuclear Medicine.Dr. Ulaner completed his medical degree and a Ph.D. in Cancer Biology at Stanford University School of Medicine, an internship at Johns Hopkins Hospital, and his Radiology and Nuclear Medicine residencies at the University of Southern California.

Chaitali Nangia, M.D., attended Lady Hardinge Medical College in New Delhi, India followed by a residency at Rush/Resurrection Westlake Hospital in Melrose Park, Illinois. She completed her fellowship in Hematology/Oncology at Josephine Ford Cancer Center at Henry Ford Hospital in Detroit, Michigan. Dr. Nangia then joined University of California Irvine as an associate professor in the Hematology/Oncology Division and associate program director of the Hematology/Oncology Fellowship program. Before joining Hoag, Dr. Nangia last spent her time as medical director at the Chan Soon Shiong Institute for Medicine where she ran several phase 1 clinical trials. Dr. Nangia is board certified in Hematology/Oncology and Internal Medicine.Dr. Nangia has a particular interest in breast cancer, as well as head and neck cancers.She has received several awards and honors throughout her career including being named Teacher of the Year for three years consecutively for the UCI Hematology/Oncology Division. Dr. Nangia has held professorships at University of California at Irvine, Michigan State University and Henry Ford Macomb Hospital in Warren, Michigan among others.She has more than two decades of research experience, serving as the primary investigator on several clinical research trials. Dr. Nangia has co-authored numerous peer-reviewed publications and abstracts and given clinical presentations throughout the U.S. and abroad. Dr. Nangia has joined Hoag to initiate a cellular therapy program, bringing solid tumor NK cell therapy to Orange County patients.She is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Southwest Oncology Group (SWOG) and the American Association of Physicians of Indian Origin (AAPIO).